Research
- Research Topics
- Cell Biology and Tumor Biology
- Stem Cells and Cancer
- Experimental Hematology
- Molecular Embryology
- Signal Transduction and Growth Control
- Epigenetics
- Redox Regulation
- Vascular Oncology and Metastasis
- Clinical Neurobiology
- Molecular Neurogenetics
- Chaperones and Proteases
- Vascular Signaling and Cancer
- Molecular Neurobiology
- Molecular Biology of Centrosomes and Cilia
- Stress-induced Activation of Hematopoietic Stem Cells
- Metastatic Niches
- DNA Repair Mechanisms and Cancer
- Neuronal Signaling and Morphogenesis
- Cell Signaling and Metabolism
- Metabolism and Stem Cell Plasticity
- Team
- Open positions
- Associated unit
- Cell Morphogenesis and Signal Transduction
- Helmholtz Professorship Molecular Biology of the Cell II
- Helmholtz Professorship Cell Biology
- Functional and Structural Genomics
- Biophysics of Macromolecules
- Molecular Genome Analysis
- Molecular Genetics
- Pediatric Neurooncology
- Cancer Genome Research
- Chromatin Networks
- Functional Genome Analysis
- Theoretical Bioinformatics
- Theoretical Systems Biology
- Neuroblastoma Genomics
- Signaling and Functional Genomics
- Signal Transduction in Cancer and Metabolism
- RNA Biology and Cancer
- Systems Biology of Signal Transduction
- Molecular thoracic Oncology
- Proteomics of Stem Cells and Cancer
- Computational Genome Biology
- Bioinformatics and Omics Data Analytics
- Mechanisms of Leukemogenesis
- Brain Tumor Translational Targets
- Molecular Genetics of Breast Cancer
- Functional Proteome Analysis
- Pediatric Glioma Research
- Cancer Risk Factors and Prevention
- Epigenomics and Cancer Risk Factors
- About The Division
- Cancer Epigenomics
- Cancer Chemoprevention and Epigenomics
- DNA Repair and Epigenomics
- Regulation of Cellular Differentiation
- Computational Epigenomics
- Methods
- Contact
- News
- Open Positions
- How to find us
- Research Program Cancer Risk Factors & Prevention
- Cancer Epidemiology
- Molecular Genetic Epidemiology
- Clinical Epidemiology and Aging Research
- Biostatistics
- Genomic Epidemiology
- Cancer Survivorship
- Molecular Epidemiology
- Epigenomics and Cancer Risk Factors
- Tumor Immunology
- Imaging and Radiooncology
- Radiology
- Research
- Contrast Agents In Radiology Research Group
- Neuro-Oncologic Imaging Research Group
- Radiological Early Response Assessment Of Modern Cancer Therapies
- Imaging In Monoclonal Plasma Cell Disorders
- 7 Tesla MRI - Novel Imaging Biomarkers
- Functional Imaging
- Visualization And Forensic Imaging
- PET/MRI
- Computed Tomography And Dual Energy CT
- Radiomics Research Group
- Prostate Research Group
- Breast Imaging Research Group
- Bone marrow
- Musculoskeletal Imaging
- Staff
- Patients
- Research
- Medical Physics in Radiology
- X-Ray Imaging and Computed Tomography
- Radiopharmaceutical Chemistry
- Medical Physics in Radiation Oncology
- Faculty & Staff
- DKFZ PhD Programm
- Research
- Computational Patient Models
- Applied Medical Radiation Physics
- Therapy Planning - Development
- Current Projects
- Former Projects
- Adaptive Radiotherapy
- Registration
- Functional Imaging
- Knowledge based radiotherapy planning (TAPIR)
- New technologies for transferring therapeutical knowledge (IRIS)
- Planning System for proton therapy of eye tumors (OCTOPUS)
- Image Processing and Represenation (VIS-A-VIS)
- Stereotactic laser neurosurgery (STELA)
- Contact
- Research Interest
- Radiotherapy Optimization
- Medical Engineering
- Novel Detection Techniques for Ion Beams
- Physical Quality Assurance in Radiation Therapy
- Ion Beam Therapy
- MR-guided RadioTherapy
- Clinical Research Group
- Publications
- Vacancies
- Awards
- Education and Training
- Events
- Biomedical Physics in Radiation Oncology
- Computer Assisted Medical Interventions
- Medical Image Computing
- Optical Nanoscopy
- Radiooncology - Radiobiology
- Radiation Oncology
- Molecular Radiooncology
- Nuclear Medicine
- Translational Radiation Oncology
- Molecular Mechanisms of Head and Neck Tumors
- Radiology
- Infection, Inflammation and Cancer
- Tumor Virology
- Molecular Diagnostics of Oncogenic Infections
- Viral Transformation Mechanisms
- Pathogenesis of Virus-Associated Tumors
- Virus-associated Carcinogenesis
- Chronic Inflammation and Cancer
- Episomal-Persistent DNA in Cancer- and Chronic Diseases
- Immunotherapy and Immunoprevention
- Cell Plasticity and Epigenetic Remodeling
- Cellular Polarity and Viral Infection
- Noroviruses
- Laboratory of Oncolytic Virus Immuno-Therapeutics
- Tumorvirus-specific Vaccination Strategies
- Mammalian Cell Cycle Control Mechanisms
- Molecular Therapy of Virus-Associated Cancers
- DNA Vectors
- Translational Cancer Research
- Translational Oncology
- Applied Functional Genomics
- Preventive Oncology
- Cellular and Molecular Pathology
- Molecular Oncology of Gastrointestinal Tumors
- Applied Bioinformatics
- Physical Activity, Prevention and Cancer
- Medical Informatics for Translational Oncology
- Molecular Therapy in Haematology and Oncology
- Health Economics
- Applied Tumor Biology
- Neuroimmunology and Brain Tumor Immunology
- Dermato-Oncology
- Molecular Hematology - Oncology
- Pediatric Oncology
- Neurooncology
- Neuropathology
- Experimental therapies for hematologic malignancies
- Adaptive Immunity and Lymphoma
- Molecular Leukemogenesis
- Neuropeptides
- Brain Cancer Metabolism
- GMP & T Cell Therapy
- Toxicology and Chemotherapy
- Immune Monitoring
- Cancer Drug Development
- Cell Biology and Tumor Biology
- Research Groups A-Z
- Junior Research Groups
- Core Facilities
- Center for Preclinical Research
- Chemical Biology Core Facility
- Genomics and Proteomics
- Imaging and Cytometry
- Information Technology
- Library
- Kataloge - Catalogues
- Zeitschriften - Journals
- E-Books - Ebooks
- Datenbanken - Databases
- Dokument-Lieferung - Document Delivery
- Publikationsdatenbank - Publication database
- DKFZ Archiv - DKFZ Archive
- Open Access
- Science 2.0
- Ansprechpartner - Contact
- More Information - Service
- Anschrift - Address
- Antiquariat - Second Hand
- Aufstellungssystematik - Shelf Classification
- Ausleihe - Circulation
- Benutzerhinweise - Library Use
- Beschaffungsvorschläge - Desiderata
- Fakten und Zahlen - Facts and Numbers
- Kooperationen, Konsortien - Cooperations, Consortia
- Kopieren, Scannen - Copying, Scans
- Kurse, Führungen - Courses, Introductions
- Öffnungszeiten - Opening Hours
- Neue Medien - New Media
- DEAL-Info
- DKFZ-Intern - internal only
- WHO Collaborating Centers
- Cooperations & Networks
- National Cooperations
- International Cooperations
- Cooperational Research Program with Israel: DKFZ - MOST in Cancer Research
- Program
- Call 2017
- Members of the Program Committee
- Generation of New Projects
- Publications
- Highlight-Projects
- 30th Anniversary of the Program
- Documentation
- Heidelberg - Israel, Science and Culture
- German-Israeli Cancer Research Schools
- Israel-Symposium, March 12, 2013
- 34th Meeting of the DKFZ-MOST Program
- DKFZ-MOST Cooperation 40th Anniversary
- Symposium 40 Years of German-Israeli Cooperation
- Helmholtz-Israel-Cooperation in Personalized Medicine
- Cooperational Research Program with Israel: DKFZ - MOST in Cancer Research
- Cooperations with industrial companies
- Helmholtz Alliances
- DKFZ PostDoc Network
- Cross Program Topic RNA@DKFZ
- Cross Program Topic Cancer Inflammation
- Cross Program Topic Epigenetics@dkfz
- Cross Program Topic Single Cell Sequencing
- iMed
- INFORM
- Baden-Württemberg Cancer Registry
PARVOVIRUS-BASED ANTICANCER THERAPIES
Group leader: Christiane Dinsart, PhD
Contact:
Christiane Dinsart, PhD
Tel. +49 6221 42 49 65
FAX +49 6221 42 49 62
Contact form
Previous and Current Research
Some cancers have a desolate prognosis and constitute obvious targets for innovative therapies including virus-based treatments. Candidate oncolytic viruses notably include autonomous parvoviruses of rodent origin (PV). The anticancer potential of these viruses is supported by a set of observations in preclinical models. Yet the mere fact that several PVs were isolated from growing tumours, and the varying sensitivity of transformed human cell cultures to PV infection, indicate that the natural viruses are not always potent enough to override cancer cell proliferation. Nevertheless, the oncotropic nature of PVs together with their low pathogenicity, make them attractive vectors for tumour-directed therapy. Over the last few years, we have designed recombinant vectors (recPV) armed with therapeutic transgenes to reinforce their anti-neoplastic activity and/or to circumvent the resistance of tumour cells to conventional treatments. Hence, recombinant vectors based on H-1PV and MVMp have been designed to deliver immunostimulatory molecules. These immunomodulators, such as cytokines will be secreted from infected cells and induce antitumour effects by activating the immune system.
Future Projects and Goals
Since many tumours, in particular brain tumours, are highly vascularised. anti-angiogenic therapies using appropriate recPVs are worth considering. Hence revPVs will also be engineered to deliver anti-angiogenic molecules. They should combine their intrinsic oncolytic activity with the expression of different anti-angiogenic molecules in the vicinity of tumours. The ability to inhibit the tumour growth will be tested using relevant pre-clinical (human) tumour models.
Our goal is thus to provide proof of concept regarding the therapeutic potency of combinatorial treatments consisting of PVs and immunostimulatory and/or anti-angiogenic molecules